Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

The Oncologist ◽

10.1634/theoncologist.2017-0069 ◽

2017 ◽

Vol 22 (7) ◽

pp. 782 ◽

Author(s):

Marco Siano ◽

Francesca Molinari ◽

Vittoria Martin ◽

Nicolas Mach ◽

Martin Früh ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Advanced Head ◽

Multicenter Phase ◽

Neck Squamous Cell Cancer

Download Full-text

Phase II study of bevacizumab with docetaxel and radiation in locally advanced head and neck squamous cell cancer

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.6071 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 6071-6071 ◽

Author(s):

P. Savvides ◽

J. Greskovich ◽

J. A. Bokar ◽

A. Narayan ◽

W. van Heeckeren ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Neck Squamous Cell Cancer

Download Full-text

A phase II study of pemetrexed (P) plus gemcitabine (G) in patients with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.5554 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 5554-5554

Author(s):

D. G. Pfister ◽

S. Haque ◽

H. Stambuk ◽

D. M. Lisa ◽

R. Shen ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Neck Squamous Cell Cancer

Download Full-text

A Randomized Phase II Study of Cetuximab Every 2 Weeks at Either 500 or 750 mg/m2for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Journal of the National Comprehensive Cancer Network ◽

10.6004/jnccn.2012.0144 ◽

2012 ◽

Vol 10 (11) ◽

pp. 1391-1398 ◽

Author(s):

Matthew G. Fury ◽

Eric Sherman ◽

Donna Lisa ◽

Neeraj Agarwal ◽

Kenneth Algazy ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Randomized Phase Ii ◽

Neck Squamous Cell Cancer

Download Full-text

A phase II study of cisplatin and continuous infusion of vindesine in metastatic head and neck squamous cell cancer

Cancer ◽

10.1002/1097-0142(19900815)66:4<640::aid-cncr2820660406>3.0.co;2-d ◽

1990 ◽

Vol 66 (4) ◽

pp. 640-644 ◽

Author(s):

Eduardo Tellez-Bernal ◽

Gonzalo Recondo ◽

Thierry Guillot ◽

Mohamed Benhamed ◽

Christian Domenge ◽

...

Keyword(s):

Head And Neck ◽

Continuous Infusion ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Neck Squamous Cell Cancer

Download Full-text

Multicenter phase II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction chemotherapy for locally advanced squamous cell cancer of the head and neck

10.1186/1471-2407-13-102 ◽

2013 ◽

Vol 13 (1) ◽

Author(s):

Woo Kyun Bae ◽

Jun Eul Hwang ◽

Hyun Jeong Shim ◽

Sang Hee Cho ◽

Ki Hyeong Lee ◽

...

Keyword(s):

Head And Neck ◽

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Locally Advanced ◽

Weekly Docetaxel ◽

Multicenter Phase

Download Full-text

8538 POSTER A Phase II Study of Induction Chemotherapy With Docetaxel, S-1, and Cisplatin in Patients With Locally Advanced Head & Neck Squamous Cell Cancer (HNSCC) – Preliminary Results

European Journal of Cancer ◽

10.1016/s0959-8049(11)72180-3 ◽

2011 ◽

Vol 47 ◽

pp. S555

Author(s):

K. Min Kyoung ◽

S.Y. Song ◽

M.K. Kang ◽

K.H. Lee ◽

H.W. Jang ◽

...

Keyword(s):

Induction Chemotherapy ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Head Neck ◽

Neck Squamous Cell Cancer

Download Full-text

A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m2 for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC).

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.5563 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 5563-5563 ◽

Author(s):

M. G. Fury ◽

E. J. Sherman ◽

D. M. Lisa ◽

N. Agarwal ◽

K. M. Algazy ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Randomized Phase Ii ◽

Neck Squamous Cell Cancer

Download Full-text

A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck – the RESGEX study

ESMO Open ◽

10.1016/j.esmoop.2021.100242 ◽

2021 ◽

Vol 6 (5) ◽

pp. 100242

Author(s):

K. Klinghammer ◽

J. Fayette ◽

A. Kawecki ◽

A. Dietz ◽

P. Schafhausen ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Efficacy And Safety ◽

Randomized Phase Ii ◽

Download Full-text

A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck

Annals of Oncology ◽

10.1093/oxfordjournals.annonc.a058905 ◽

1994 ◽

Vol 5 (6) ◽

pp. 513-519 ◽

Author(s):

P. Pinnarò ◽

M.C. Cercato ◽

D. Giannarelli ◽

P. Carlini ◽

M.R. Del Vecchio ◽

...

Keyword(s):

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Phase Ii Study ◽

Cell Cancer ◽

Locally Advanced ◽

Randomized Phase Ii

Download Full-text

Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.02.088 ◽

2017 ◽

Vol 98 (4) ◽

pp. 948-954 ◽

Author(s):

June Corry ◽

Mathias Bressel ◽

Tsien Fua ◽

Alan Herschtal ◽

Benjamin Solomon ◽

...

Keyword(s):

Radiation Therapy ◽

Prospective Study ◽

Head And Neck ◽

Squamous Cell ◽

Squamous Cell Cancer ◽

Cell Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Neck Squamous Cell Cancer

Download Full-text